About Instil Bio (TIL)
Instil Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing a cell therapy pipeline of autologous tumor-infiltrating lymphocyte (TIL) therapies for the treatment of patients with cancer. TIL therapies leverage... Read more
- USD10.90
- USD10.93
- USD10.53
- USD14.00
- 0.20%
- --
- 6.22k
- 10.10k
- 69M
- 6.07
- -17.20%
Stock News
2 hours ago
Herbalife Reports Year-Over-Year Net Sales Growth for Second Consecutive Quarter; Raises Full-Year 2024 Adjusted EBITDA1 Guidance
Yahoo
2 hours ago
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
Yahoo
2 hours ago
Sunoco LP and NuStar Energy L.P. Announce NuStar's Unitholder Approval of the Sunoco Transaction
Yahoo
3 hours ago
Embarking on History: Concord Pacific Racing Propels Team Canada's Pursuit of the Inaugural Puig Women's America's Cup
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
